Back to the main directory
Press Release
- STMicroelectronics Announces Status of Common Share Repurchase Program by GlobeNewsWire
- Ilkka-konsernin tulosjulkistukset ja yhtiökokous vuonna 2023 by GlobeNewsWire
- WillScot Mobile Mini Holdings to Participate in the Deutsche Bank Industrials Conference by GlobeNewsWire
- Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th by GlobeNewsWire
- Noranda Income Fund Confirms Third Quarter 2022 Results Release Date by GlobeNewsWire
- Los Angeles County Awards NV5 $6 Million Environmental Services Contract by GlobeNewsWire
- ORYZON Announces Oral Data Presentation at the Upcoming 64th American Society of Hematology Annual Conference by GlobeNewsWire
- XWELL to Bring Robotic Manicures to US Airports Through New Partnership with Clockwork by GlobeNewsWire
- EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences by GlobeNewsWire
- HII Unveils REMUS 620 Unmanned Underwater Vehicle by GlobeNewsWire
- Cue Biopharma to Host Business Update Call and Webcast by GlobeNewsWire
- Akerna to Announce Financial Results for the Third Quarter of 2022 on November 14, 2022 by GlobeNewsWire
- Fate Therapeutics Announces Exercise by ONO Pharmaceutical of Option to HER2-targeted CAR T-Cell Product Candidate for Solid Tumors by GlobeNewsWire
- 23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting by GlobeNewsWire
- Else Nutrition to Report Third Quarter 2022 Financial Results on November 14, 2022 by GlobeNewsWire
- Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended September 30, 2022 and Declaration of Distributions on Common Stock for the Months Ending January 31, February 28, and March 31, 2023 by GlobeNewsWire
- PDS Biotech Announces Presentation of Preliminary PDS0101 Efficacy, Safety, and Immunology Data at Society for Immunotherapy of Cancer (SITC 2022) by GlobeNewsWire
- TCR² Therapeutics Presents Preclinical Data on Functional Activity of Gavo-cel at the Society for Immunotherapy of Cancer by GlobeNewsWire
- EQRx to Participate in the Jefferies 2022 London Healthcare Conference by GlobeNewsWire
- Alaunos Therapeutics to Present Data Highlighting its hunTR™ TCR Discovery Platform at the Society for Immunotherapy of Cancer 2022 Annual Meeting by GlobeNewsWire
- Humacyte Presents Six-Month Human Acellular Vessel™ (HAV™) Coronary Artery Bypass Graft (CABG) Data at the American Heart Association Scientific Sessions 2022 Meeting by GlobeNewsWire
- Candel Therapeutics Announces Upcoming Clinical Data Presentations at SITC and SNO by GlobeNewsWire
- H2O Innovation : la ligne d’affaires Érablière lance un concept technologique unique de magasin conteneurisé libre-service 24/7 by GlobeNewsWire
- Sabina Gold & Silver Reports on Project Activities by GlobeNewsWire
- ReWalk Robotics Reports Third Quarter 2022 Financial Results by GlobeNewsWire